Sharpening Pharma's Data Integrity with Automation

In this Pharma Manufacturing article, Michalle Adkins, director of life sciences strategy for Emerson’s process systems and solutions business, explains how the built-in ability to meet data integrity standards should be a central focus when selecting control systems and manufacturing execution systems for pharma manufacturing.

Latest News

Emerson Ventures Invests in Symmera

Emerson today announced it has made a strategic investment through its corporate venture capital arm Emerson Ventures in Symmera, an early-stage...

Emerson Ventures Invests in First Resonance

Strategic investment from Emerson’s corporate venture capital arm supports First Resonance's ION Factory Operating System

Emerson Ventures Makes Strategic Investment in Spearix

Emerson has made a strategic investment through Emerson Ventures, its corporate venture capital arm, in Spearix Technologies, Inc., whose...
Please enable JavaScript to use this website.